Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues (Q40484689)

20 September 2017

Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues (English)

1 reference

20 September 2017

1 reference

Xiao Ang Yang

1

1 reference

20 September 2017

Xue Yuan Dong

2

1 reference

20 September 2017

Huan Qiao

3

1 reference

20 September 2017

Yue Dan Wang

4

1 reference

20 September 2017

Ji Run Peng

5

1 reference

20 September 2017

Yan Li

6

1 reference

20 September 2017

Xue Wen Pang

7

1 reference

20 September 2017

Chan Tian

8

1 reference

20 September 2017

Wei Feng Chen

9

1 reference

20 September 2017

1 February 2005

1 reference

20 September 2017

Laboratory Investigation

1 reference

20 September 2017

85

1 reference

20 September 2017

2

1 reference

20 September 2017

205-213

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700220

20 September 2017

0 references

cites work

Human neoplasms elicit multiple specific immune responses in the autologous host

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Identification and characterization of a novel cancer/testis antigen gene CAGE-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

SSX: a multigene family with several members transcribed in normal testis and human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Human FATE is a novel X-linked gene expressed in fetal and adult testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Purification and refolding of a novel cancer/testis antigen BJ-HCC-2 expressed in the inclusion bodies of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Cancer/testis antigens: structural and immunobiological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Immunotherapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Expression of SSX genes in human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

WT1 as a novel target antigen for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Wilms' tumor gene WT1: its oncogenic function and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Adenosine stimulation of proliferation of breast carcinoma cell lines: evaluation of the [3H]thymidine assay system and modulatory effects of the cellular microenvironment in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

T cell defined tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

7 January 2021

Cancer Tumor antigens

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

7 January 2021

mRNA detection of tumor-rejection genes BAGE, GAGE, and MAGE in peritoneal fluid from patients with ovarian carcinoma as a potential diagnostic tool

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

7 January 2021

Expression of MAGE-antigens in normal tissues and cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

7 January 2021

Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700220

7 January 2021

10.1038/LABINVEST.3700220

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference